Something's up with this company besides the upgrade. There must be something in the pipeline that is going to be announced just like CYTX. FDA approval? Anyone? This was a high flying stock 2000-2006 and then what happened? Could someone be interested in an aquisition or is it huge institutional buying? This has run up quickly in the last few days of trading.
It was high flying on hopes for a sleep drug called Indiplon. It was not approved by the FDA in May 2006 submission and then turned down again in December 2007 on a resubmission. Indiplon hasn't been heard from since.